Platelet-to-Lymphocyte Ratio as Marker of Platelet Activation in Patients on Potent P2Y Inhibitors

Platelet-to-Lymphocyte Ratio as Marker of Platelet Activation in Patients on Potent P2Y Inhibitors

A high platelet-to-lymphocyte ratio (PLR) has recently been associated with ischemic outcomes in cardiovascular disease. Increased platelet reactivity and leukocyte-platelet aggregate formation are directly involved in the progress of atherosclerosis and have been linked to ischemic events following...

Full description

Bibliographic Details
Main Authors:	Patricia P. Wadowski MD, PhD, Joseph Pultar, Constantin Weikert, Beate Eichelberger, Maximilian Tscharre MD, PhD, Renate Koppensteiner MD, Simon Panzer MD, Thomas Gremmel MD, MBA
Format:	Article
Language:	English
Published:	SAGE Publishing 2022-04-01
Series:	Journal of Cardiovascular Pharmacology and Therapeutics
Online Access:	https://doi.org/10.1177/10742484221096524

Similar Items

Protease‐activated receptor‐mediated platelet aggregation in acute coronary syndrome patients on potent P2Y12 inhibitors
by: Patricia P. Wadowski, et al.
Published: (2019-07-01)

Growth Differentiation Factor 15 Is Associated with Platelet Reactivity in Patients with Acute Coronary Syndrome
by: David Mutschlechner, et al.
Published: (2023-02-01)

Platelet-to-lymphocyte and Neutrophil-to-lymphocyte Ratios Predict Target Vessel Restenosis after Infrainguinal Angioplasty with Stent Implantation
by: Silvia Lee, et al.
Published: (2020-06-01)

Comparison of Aggregometry with Flow Cytometry for the Assessment of Agonists´-Induced Platelet Reactivity in Patients on Dual Antiplatelet Therapy.
by: Thomas Gremmel, et al.
Published: (2015-01-01)

Prognostic Value of Platelet-to-Lymphocyte Ratio, Neutrophil-to-Lymphocyte Ratio, and Lymphocyte-to-White Blood Cell Ratio in Colorectal Cancer Patients Who Received Neoadjuvant Chemotherapy
by: Wangqiang Jia MD, et al.
Published: (2021-07-01)

Interleukin-6 and asymmetric dimethylarginine are associated with platelet activation after percutaneous angioplasty with stent implantation.
by: Thomas Gremmel, et al.
Published: (2015-01-01)

Platelet activation and aggregation in different centrifugal-flow left ventricular assist devices
by: Maximilian Tscharre, et al.
Published: (2022-02-01)

Neutrophil-to-Lymphocyte and Platelet-to-Lymphocyte Ratios Predict All-Cause Mortality in Acute Pulmonary Embolism
by: Trung Phan MD, et al.
Published: (2020-01-01)

Growth Differentiation Factor-15 Correlates Inversely with Protease-Activated Receptor-1-Mediated Platelet Reactivity in Patients with Left Ventricular Assist Devices
by: Maximilian Tscharre, et al.
Published: (2022-04-01)

Underlying mechanism and specific prevention of hemolysis-induced platelet activation
by: Thomas Gremmel, et al.
Published: (2017-08-01)

Impact of diabetes on platelet activation in different manifestations of atherosclerosis
by: Thomas Gremmel, et al.
Published: (2013-05-01)

Assessment of the Clinical Value of Platelet-to-Lymphocyte Ratio in Patients with Hepatocellular Carcinoma
by: Xu Chen MD, et al.
Published: (2024-04-01)

The Diagnostic Value of the Neutrophil-to-Lymphocyte Ratio and Platelet-to-Lymphocyte Ratio for Deep Venous Thrombosis: A Systematic Review and Meta-Analysis
by: Chenming Hu BS, et al.
Published: (2023-07-01)

Lymphocytes, Mean Platelet Volume, and Albumin in Critically Ill COVID-19 Patients with Venous Thromboembolism
by: Rundan Duan MD, et al.
Published: (2023-05-01)

Platelet Acetyl-CoA Carboxylase Phosphorylation
by: Shakeel Kautbally, MD, et al.
Published: (2019-09-01)

Predictive Value of the Platelet-to-Lymphocyte Ratio in Cancer Patients Undergoing Transcatheter Aortic Valve Replacement
by: Noriaki Tabata, MD, et al.
Published: (2019-12-01)

Antibodies against complement-regulatory proteins on platelets in immune thrombocytopenia
by: Ursula Unterberger, et al.
Published: (2017-05-01)

Impact of Edoxaban on Thrombin-Dependent Platelet Aggregation
by: Juraj Sokol MD, PhD, et al.
Published: (2020-10-01)

High On-Treatment Platelet Reactivity in Patients Undergoing Complex Percutaneous Coronary Interventions
by: Lukáš Urban MD, PhD, et al.
Published: (2023-09-01)

Microvascular Thrombosis as a Critical Factor in Severe COVID-19
by: Patricia P. Wadowski, et al.
Published: (2023-01-01)

Evaluation of Neutrophil-Lymphocyte Ratios, Mean Platelet Volumes, and Platelet-Lymphocyte Ratios in Pterygium
by: Onur Gökmen, et al.
Published: (2019-12-01)

The effect and correlation of smoking with platelet indices, neutrophil lymphocyte ratio and platelet lymphocyte ratio
by: Mukta Pujani, et al.
Published: (2021-10-01)

Influence of Platelet Rich Plasma on the Skeletal Muscle Fibrosis after Limb Lengthening in Mice
by: Ichiro Tonogai MD, PhD, et al.
Published: (2020-10-01)

Platelet-Rich Plasma Augmentation for Hip Arthroscopy
by: Sandeep Mannava, M.D., Ph.D., et al.
Published: (2017-06-01)

Intraosseous Infiltration of Platelet-Rich Plasma for Severe Knee Osteoarthritis
by: Mikel Sánchez, M.D., et al.
Published: (2014-12-01)

Biomarkers of Platelet Activation and Their Prognostic Value in Patients With Sepsis-Associated Disseminated Intravascular Coagulopathy
by: Gracelene Wegrzyn MD, et al.
Published: (2021-02-01)

Increased Levels of Platelets and Endothelial-Derived Microparticles in Patients With Non-Valvular Atrial Fibrillation During Rivaroxaban Therapy
by: Aleksandra Lenart-Migdalska MD, et al.
Published: (2021-05-01)

The role of platelet-rich plasma therapy in refractory folliculitis decalvans
by: Susie Suh, BA, et al.
Published: (2021-06-01)

Intraosseous Infiltration of Platelet-Rich Plasma for Severe Hip Osteoarthritis
by: Nicolás Fiz, M.D., et al.
Published: (2017-06-01)

Impact of Stereotactic Body Radiotherapy on Thrombin Generation and Platelet Aggregation in Patients with Non-Small Cell Lung Cancer
by: Kristian Kirkelund Bentsen MD, et al.
Published: (2023-11-01)

Neutrophil Subsets, Platelets, and Vascular Disease in Psoriasis
by: Heather L. Teague, PhD, et al.
Published: (2019-02-01)

Assessment of Risk Factors for Drug Resistance of Dual Anti Platelet Therapy After PCI
by: Lijie Zhang PhD, MD, et al.
Published: (2022-03-01)

Investigation of changes in serum thiols and neutrophil-to-lymphocyte ratio, monocyte-to-lymphocyte ratio, platelet-to-lymphocyte ratio, and mean platelet volume/platelet count ratio indices in cats undergoing ovariohysterectomy
by: Tuğra Akkuş, et al.
Published: (2023-05-01)

Association of Soluble Suppression of Tumorigenesis 2 (sST2) With Platelet Activation, Monocyte Tissue Factor and Ischemic Outcomes Following Angioplasty and Stenting
by: Stefan Stojkovic, et al.
Published: (2020-12-01)

Neutrophil-to-Lymphocyte Ratio, Platelet-to-Lymphocyte Ratio and Heart Failure
by: Viroj Wiwanitkit
Published: (2016-03-01)

Platelet to Lymphocyte Ratio and Neutrophil to Lymphocyte Ratio in Missed Abortion
by: Ismail Biyik, et al.
Published: (2020-06-01)

Platelet lymphocyte ratio, lymphocyte monocyte ratio, mean platelet volume, and neutrophil lymphocyte ratio in Behcet’s disease and their relation to disease activity
by: Zahraa I. Selim, et al.
Published: (2023-01-01)

Prognostic Value of Neutrophil–Lymphocyte Ratio, Platelet–Lymphocyte Ratio, and Combined Neutrophil–Lymphocyte Ratio and Platelet–Lymphocyte Ratio in Stage IV Advanced Gastric Cancer
by: Huan Wang, et al.
Published: (2020-06-01)

Predicting Microvascular Thrombotic Complications with Thromboelastography and Platelet Mapping: A Preliminary Investigation
by: Jiaxi Chen, MD, et al.
Published: (2021-10-01)

Peripheral versus central venous blood sampling does not influence the assessment of platelet activation in cirrhosis
by: Ksenia Brusilovskaya, et al.
Published: (2022-08-01)